Crossmark

Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases

Crossref DOI link: https://doi.org/10.1186/s40168-018-0604-3

Published Online: 2019-01-03

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Armstrong, Heather

Alipour, Misagh

Valcheva, Rosica

Bording-Jorgensen, Michael

Jovel, Juan

Zaidi, Deenaz

Shah, Prachi

Lou, Yuefei

Ebeling, Cory

Mason, Andrew L.

Lafleur, Dawson

Jerasi, Jeremy

Wong, Gane K.-S.

Madsen, Karen

Carroll, Matthew W.

Huynh, Hien Q.

Dieleman, Levinus A.

Wine, Eytan
Funding

Funding for this research was provided by:

Crohn's and Colitis Canada

Crohn's and Colitis Foundation

Alberta Innovates - Health Solutions

WCHRI

Institute of Nutrition, Metabolism and Diabetes

Canadian Association of Gastroenterology
License Information

Text and Data Mining valid from 2019-01-03
More Information

Article History

Received: 5 July 2018

Accepted: 25 November 2018

First Online: 3 January 2019

Ethics approval and consent to participate

: Consent was obtained from patients/guardians, and the study was approved by the Health Research Ethics Board at the University of Alberta (Study ID Pro00023820), Edmonton, AB, Canada.

: All authors grant consent for the publication of the data within this manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.